Skip to content

Author

Hiroaki Takei

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Post-Treatment Performance Status and Prognosis in Patients with Brain Metastases as the First Manifestation of Advanced Non-Small Cell Lung Cancer.

Favorable post-treatment PS was associated with longer OS and the use of tyrosine kinase inhibitors or immune checkpoint inhibitors, relative to conventional chemotherapy, were associated with longer OS.

K. Shoda, Takayuki Nishiwak, Hiroaki Takei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.